Item 2.02. Disclosure of Results of Operations and Financial Condition.
On January 30, 2020 we issued the press release attached as Exhibit 99.1. It is
incorporated into this report by reference. The press release describes the
results of our operations for the quarter ended December 31, 2019.
Item 8.01. Other Events.
On January 30, 2020 we announced that our board of directors declared a
quarterly cash dividend of US $0.39 per share. The dividend will have a record
date of February 13, 2020, payable on March 19, 2020. The dividend will be paid
in U.S. currency to holders of ResMed's common stock trading on the New York
Stock Exchange. Holders of Chess Depositary Instruments trading on the
Australian Securities Exchange will receive an equivalent amount in Australian
currency, based on the exchange rate on the record date, and reflecting the 10:1
ratio between CDIs and NYSE shares. The ex-dividend date will be February 12,
2020, for common stockholders and for CDI holders. ResMed has received a waiver
from the ASX's settlement operating rules, which will allow ResMed to defer
processing conversions between its common stock and CDI registers from
February 12, 2020, through February 13, 2020, inclusive.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibits: Description of Document
99.1 Press Release dated January 30, 2020 regarding results of
operations
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
-2-
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses